Home About Us Media Kit Subscriptions Links Forum
 
APPEARED IN


View All Articles

Download PDF

FAMOUS INTERVIEWS

Directories:

SCHOLARSHIPS & GRANTS

HELP WANTED

Tutors

Workshops

Events

Sections:

Books

Camps & Sports

Careers

Children’s Corner

Collected Features

Colleges

Cover Stories

Distance Learning

Editorials

Famous Interviews

Homeschooling

Medical Update

Metro Beat

Movies & Theater

Museums

Music, Art & Dance

Special Education

Spotlight On Schools

Teachers of the Month

Technology

Archives:

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

1995-2000


SEPTEMBER 2008

Easing the Pain of Diabetes

To ease pain and numbness associated with diabetes, NewYork-Presbyterian/Weill Cornell physician-scientists are studying a drug previously used for depression to treat peripheral neuropathy. Diabetics often suffer from this condition because of high blood sugar levels that damage nerve cells. Those with peripheral neuropathy often endure chronic pain, cramping and sleepless nights that prevent them from living a normal lifestyle.

But now, scientists believe that a drug called reboxetine may alleviate their symptoms. The compound works by boosting the level of the neurotransmitter norepinephrine between nerve cells. But it also works by inhibiting the neurotransmitter's degradation within the nerve, where it is stored within the cell for later use.

Dr. Bassem Masri—a cardiologist and diabetes specialist at New York-Presbyterian/Weill Cornell and Helen and Robert Appel Clinical Scholar and assistant professor of clinical medicine at Weill Cornell Medical College—is studying the drug's effectiveness in a Phase II trial in subjects who have been diagnosed with diabetes for at least one-year and who have peripheral neuropathy.

For more information: Please contact Ivanka Zaprianov at 212-746-2349.#

COMMENT ON THIS ARTICLE

Name:

Email:
Show email
City:
State:

 


 

 

 

Education Update, Inc.
All material is copyrighted and may not be printed without express consent of the publisher. © 2008.